Quality of glycaemic control in ambulatory diabetics at the out-patient clinic of Kenyatta National Hospital, Nairobi

East African Medical Journal

Volumn 80, Issue 8, 2003, Pages 406-410

  Otieno, C F ^a   Kariuki, M ^b   Ng'ang'a, L ^c  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b KENYATTA NATIONAL HOSPITAL   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EPIDEMIOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KENYA; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; RANDOMIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KENYA; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; RANDOM ALLOCATION; SAMPLING STUDIES;

EID: 23944472762     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. World Health Organization. In: "World Health Report. (Africa) conquering suffering, enriching humanity" World Health Organization, Geneva. 1997.
2. King, H.: Problems associated with the costs of diabetes care in Africa and Asia: a World Health Organization perspective. In: The Economics of Diabetes Care: An International perspective. Editors: Rhys Williams, Tuomilehto, J., Bjork, S., Blackwell Science. 2000; 61-68.
3. The Diabetes Control and Complications Trial Research Group.: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. New. Eng. J. Med. 1993; 329:977-986.
4. UK Prospective Diabetes Study (UKPDS) Group.: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-853
5. Yearly records, Kenyatta National Hospital, 1997.
6. Alberti, K.G.M.M. and Zimmet, P.Z., for WHO consultation.: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of WHO consultation. Diabetes Med. 1998; 15:539-553.
7. Okhubo, Y., Kishikawa, H., Araki, E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with NIDDM: A randomized prospective six-year study. Diabetes Res. Clin. Pract. 1995; 28:103-117.
8. Claudi, T., Cooper, J., Skogoy, K., et al. Diabetesomsorg, I morsk allmennpraksis - En tilstandsrapport fra salten og deler av Rogaland. Tidsskr Nor Loegeforen. 1997; 117:3661-3664.
9. Gebre-Yohannes, A., and Rahlenbeck, S. I. Glycaemic control and its determinants in diabetic patients in Ethiopia. Diabetes-Res Clinical Pract. 1997; 35:129-134
10. Blaum, C.S., Velez, L., Hiss, R. G., and Halter J. B. Characteristics related to poor glycaemic control in NIDDM patients in community practice. Diabetes Care. 1997; 20:7-10.
11. McLarty, D.G., Swai, A.B.M., and Alberti, K.G.M. M. Insulin availability in Africa an insoluble problem? Int. Diabetes Dig. 1994; 5:15-17.
12. Mbanya, J. C. Diabetes Care in Cameroon. Int. Diabetes Dig. 1993; 4:146-150.
13. U.K. Prospective Diabetes Study Group.: Overview of six years' therapy of type 2 diabetes. A progressive disease. UKPDS (16). Diabetes. 1995; 14:1249-1258.
14. Sonnaville, J.J.J., Snoek, K.F.J., Colly, L.P., et al. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care. 1998; 21:919-924.
15. DeFronzo, R.A. Pharmacologic therapy for type 2 diabetes mellitus - Review. Ann. Intern. Med. 1999; 131:286-303
16. White, J. R. The pharmacological reduction of Blood Glucose in patients with type 2 diabetes mellitus. Clinical Diabetes. 1998; 16:58-67.
17. Wallace, T.M. and Mathews D.R. Poor glycaemic control in type 2 diabetes: A conspiracy of disease, sub-optimal therapy and attitude. Quart. J. Med. 2000; 93:369-374.